Form D · Other Health Care
Enthrive Inc.
Toronto, A6 · CIK 0001591326
Offering snapshot reported Nov 8, 2013 · SEC filing
- Reported sold
- $75K Offering amount: $75K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $75K Reported outside-investor minimum
- First sale
- Oct 30, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 8, 2013 | Initial | $75,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-206007
The total offering amount was CDN$1,000,000, only US$75,000 (CDN$76,485) of this offering was sold in the United States or to U.S. Persons. All other sales were made outside the United States to non U.S. Persons.
Source: Form D, filed Nov 8, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alexandra Aleskovsky | Director |
| Jason De Zwirek | Director |
| Jonathan Graff | Director, Executive |
| Leonard Latchman | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2300 Yonge Street, Suite 1901
Toronto, A6, M4P 1E4
Toronto, A6, M4P 1E4